NewsBenzingaArtiva Biotherapeutics、AlloNK試験の契約解除およびその他費用を1,000万~1,500万ドルと見積もり、人員削減関連費用を1,700万~2,000万ドルと見積もり Artiva Biotherapeutics、AlloNK試験の契約解除およびその他費用を1,000万~1,500万ドルと見積もり、人員削減関連費用を1,700万~2,000万ドルと見積もり Benzinga 2026.11.09 22:18 (GMT+0) Open on Benzinga Other news Nvidia’s $105 Billion OpenAI Bet Has a 20-Year Catch Freedom Broker Upgrades Espey Manufacturing to Buy, Maintains Price Target to $70 QUICK SPARK: Chip Stocks Eye Worst Two-Month Drop Since 2008 Carlyle, Clearlake Bet Big On Sports — And PE Deals Are Surging Target's $301 Million Tariff Windfall 'Flattered' Earnings, Analyst Says Freedom Broker Maintains Buy on SKYX Platforms, Lowers Price Target to $2